genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2012
AVI BioPharma
News
AVI BioPharma Weighs Next Steps After Mixed Phase II Results with DMD Therapy
Infectious Diseases
AVI BioPharma Obtains Expanded DoD Contract Worth $11.5M for Its Junin Virus Infection Treatment
News
U.K. DMD Charity to Provide AVI BioPharma $1.2M to Progress Drugs
News
Charley’s Fund Adds $3M in Research Support for AVI’s Therapy for Duchenne Muscular Dystrophy
News
AVI to Acquire Ercole in Deal Worth About $7.5M
News
Morphotek and AVI BioPharma Ink DoD Biodefense Contracts
News
AVI BioPharma Receives DoD Contracts Worth over $7M
News
AVI and Ercole Take On Duchenne Muscular Dystrophy and Beta Thalassemia
News
AVI BioPharma Recipient of $28M Biodefense Contract
Scroll Up
Scroll Up
